+
Site Tour

bRIGHT study 1-year data card

Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.

Download

Related Resources

ESC 2021: HF & VHD Guidelines

PCR LV 2021: Navitor™ Live-in-a-box

Navitor Valve in small aortic annuli

2-year outcomes from the TRILUMINATE Pivotal trial

PCR LV 2021: Navitor™ Looking ahead

Poster: Primary MR in the Very Elderly

EXPAND Study: Data overview

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRENDING TOPICS

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 25, presented by G. Singh

Poster: Primary MR in the Very Elderly

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

CONNEXT


TV
RELATED RESOURCES

ESC 2023 HF Satellite Symposium

EuroPCR 25 Symposium: MitraClip and TriClip

Navitor™: Voice of the Experts Lars Sondergaard

Navigating the Anatomy | Tricuspid focus

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: The Genesis of TEER

TAVI Summit - Drive TAVI to the next level

AV VALVES 2023: TR – Big Gaps

AV Valves Summit 2024 | Closing of Day 2

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline